Dr. Salehi’s team (Stanford) just showed that “boosting” Norepinephrine would allow—if the intervention is made early enough—to raise the number of key neurotransmitters. The Norepinephrine is already being tested clinically against Fibromyalgia.
Dr. Salehi’s team (Stanford) just showed that “boosting” Norepinephrine would allow—if the intervention is made early enough—to raise the number of key neurotransmitters. The Norepinephrine is already being tested clinically against Fibromyalgia.